Prospective, randomized, double-blind study assessing the effects of levetiracetam compared to placebo in the prevention of early epileptic seizures and late epilepsy in patients with severe traumatic brain injury.

Trial Profile

Prospective, randomized, double-blind study assessing the effects of levetiracetam compared to placebo in the prevention of early epileptic seizures and late epilepsy in patients with severe traumatic brain injury.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 20 Jun 2012

At a glance

  • Drugs Levetiracetam (Primary)
  • Indications Epilepsy
  • Focus Therapeutic Use
  • Acronyms TRACK
  • Most Recent Events

    • 01 Mar 2012 Actual patient number is 23 according to ClinicalTrials.gov.
    • 05 Aug 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 11 Dec 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top